Profile Picture

Swaroopkumar Venkata Satya Vakkalanka - Profile

Swaroopkumar Venkata Satya Vakkalanka, Managing Director and Director, with 10 companies.

About Swaroopkumar Venkata Satya Vakkalanka

Swaroopkumar Venkata Satya Vakkalanka has 18 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including Zanthera Pharmaceuticals Private Limited and Sirak Pharmaceuticals Private Limited. Formerly with 6 companies, such as Fenix Research Labs Private Limited and Zanthera Pharmaceuticals Private Limited. Engaged in General Business.

Current Companies 4
Past Companies 6
Total Affiliations 10
Oldest Company Age 18
Companies Associated with Swaroopkumar Venkata Satya Vakkalanka
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Swaroopkumar Venkata Satya Vakkalanka?

Swaroopkumar Venkata Satya Vakkalanka has 18 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including Zanthera Pharmaceuticals Private Limited and Sirak Pharmaceuticals Private Limited. Formerly with 6 companies, such as Fenix Research Labs Private Limited and Zanthera Pharmaceuticals Private Limited. Engaged in General Business.

What is Swaroopkumar Venkata Satya Vakkalanka's role in current companies?

Swaroopkumar Venkata Satya Vakkalanka is associated with 4 companies as Managing Director and Director.

What industries does Swaroopkumar Venkata Satya Vakkalanka specialize in?

Swaroopkumar Venkata Satya Vakkalanka has expertise in General Business.

How many years of experience does Swaroopkumar Venkata Satya Vakkalanka have?

Swaroopkumar Venkata Satya Vakkalanka has 18 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available